Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2025-02-20 Earnings Release
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
LIFE: Lifecare ASA Q4 2024
Earnings Release Classification · 1% confidence The document explicitly states, "Today, Lifecare ASA (LIFE) (the "Company"), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes its Q4 2024 financial report and operational update." This indicates the release of periodic financial results. The content includes key highlights, operational progress, and financial context for the quarter, which aligns perfectly with an Earnings Release (ER). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), but rather the initial announcement of the period's results. Q4 2024
2025-02-20 English
Financial calendar
Report Publication Announcement Classification · 1% confidence The document is titled "Financial calendar" and lists future dates for key corporate events like the Annual Report, Quarterly Reports, and the Annual General Meeting (AGM). It is not the report itself, nor is it a transcript or a specific financial filing. It is an announcement detailing the schedule of future corporate disclosures and meetings. Since it is an announcement about the timing and publication of reports/meetings, it fits best under Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports. The document length is very short (587 chars), supporting the classification as an announcement rather than the full report.
2025-02-14 English
LIFE: Improved chemistry successfully tested in sensor
Regulatory Filings Classification · 1% confidence The document is a press release dated February 4, 2025, announcing the successful testing of improved sensor chemistry for Lifecare ASA's Continuous Glucose Monitor (CGM). It details technical progress, mentions previous study results (MARD of 9.7% in Q2 2023), and provides company background and contacts. This type of announcement, focusing on operational or technological milestones rather than mandatory periodic financial reporting (like 10-K or IR) or specific corporate actions (like DIV or DIRS), typically falls under general regulatory announcements or news releases. Since it is not a formal financial report, an earnings release (ER), or a specific corporate action filing, the most appropriate general category is Regulatory Filings (RNS), which serves as a catch-all for significant, non-standard announcements. Given the short length (3473 chars) and the nature of announcing a test result and future plans, it is not a comprehensive report like an IR or 10-K. It is a specific operational update.
2025-02-04 English
LIFE: Improved chemistry successfully tested in sensor
Regulatory Filings Classification · 1% confidence The document is a short announcement dated February 4, 2025, from Lifecare ASA regarding the successful testing of improved sensor chemistry in their Continuous Glucose Monitor (CGM). It details technical progress, mentions previous study results (MARD of 9.7% in Q2 2023), and includes quotes from the CEO. This content is characteristic of a press release or a general operational update intended for investors and the public, rather than a formal regulatory filing like a 10-K, IR, or a specific financial report. Since it is an announcement of operational/technical progress and not a specific financial report, dividend notice, or management change, it best fits the general 'Regulatory Filings' (RNS) category as a miscellaneous regulatory announcement, or potentially an Earnings Release (ER) if it were tied to a specific reporting period, but it reads more like a standalone operational update. Given the options, RNS is the most appropriate fallback for a general corporate announcement that doesn't fit the highly specific financial/governance codes.
2025-02-04 English
Financial calendar
Report Publication Announcement Classification · 1% confidence The document is titled "Financial calendar" and lists future dates for key corporate events such as the Annual Report, Quarterly Reports, and the Annual General Meeting (AGM). It is not a report itself, nor is it a specific announcement about a past event like a dividend or director dealing. It is a forward-looking schedule of corporate reporting events. This type of scheduling information does not fit neatly into the defined categories (like 10-K, ER, IR, etc.). Therefore, the most appropriate fallback category is Regulatory Filings (RNS), as it is a general corporate announcement required under continuing obligations.
2025-01-16 English
LIFE Fivefold improvement of sensor chemistry sensitivity
Regulatory Filings Classification · 1% confidence The document is a press release dated January 14, 2025, announcing a significant technical improvement in the company's sensor chemistry, specifically related to Continuous Glucose Monitor (CGM) sensitivity. It details performance metrics (MARD) and future product expectations. This type of announcement, focusing on operational or technological milestones rather than formal financial results (like 10-K or IR) or management changes (MANG), typically falls under a general regulatory announcement or news release. Since it is not a formal financial report, a transcript, or a specific corporate action notice (like dividend or share issue), it best fits the general 'Regulatory Filings' (RNS) category, which serves as a fallback for significant, non-standard corporate news releases. It is too detailed to be a simple Report Publication Announcement (RPA) as it contains substantive news, not just a notice about another report.
2025-01-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.